NDC 71335-0073

GABAPENTIN

Gabapentin

GABAPENTIN is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Gabapentin.

Product ID71335-0073_82a03360-4484-49e0-8340-06835cf78d97
NDC71335-0073
Product TypeHuman Prescription Drug
Proprietary NameGABAPENTIN
Generic NameGabapentin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2016-06-29
Marketing CategoryANDA / ANDA
Application NumberANDA090705
Labeler NameBryant Ranch Prepack
Substance NameGABAPENTIN
Active Ingredient Strength100 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 71335-0073-0

65 CAPSULE in 1 BOTTLE (71335-0073-0)
Marketing Start Date2021-12-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-0073-5 [71335007305]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-30
Marketing End Date2018-06-30

NDC 71335-0073-0 [71335007300]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-30
Marketing End Date2018-06-30

NDC 71335-0073-3 [71335007303]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-30
Marketing End Date2018-06-30

NDC 71335-0073-1 [71335007301]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-30
Marketing End Date2018-06-30

NDC 71335-0073-7 [71335007307]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-30
Marketing End Date2018-06-30

NDC 71335-0073-9 [71335007309]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-30
Marketing End Date2018-06-30

NDC 71335-0073-6 [71335007306]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-30
Marketing End Date2018-06-30

NDC 71335-0073-2 [71335007302]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-30
Marketing End Date2018-06-30

NDC 71335-0073-4 [71335007304]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-30
Marketing End Date2018-06-30

NDC 71335-0073-8 [71335007308]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-30
Marketing End Date2018-06-30

Drug Details

Active Ingredients

IngredientStrength
GABAPENTIN100 mg/1

OpenFDA Data

SPL SET ID:97a1d45d-d5b3-4be7-9b3a-cb6f80f60291
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310430

    • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    NDC Crossover Matching brand name "GABAPENTIN" or generic name "Gabapentin"

    NDCBrand NameGeneric Name
    0093-4443GabapentinGabapentin
    0093-4444GabapentinGabapentin
    0143-3991GabapentinGabapentin
    0143-3993GabapentinGabapentin
    0143-3994GabapentinGabapentin
    0143-9992GabapentinGabapentin
    0143-9993GabapentinGabapentin
    0143-9994GabapentinGabapentin
    67877-222GabapentinGabapentin
    67877-223GabapentinGabapentin
    67877-224GabapentinGabapentin
    67877-428GabapentinGabapentin
    67877-429GabapentinGabapentin
    68001-006GabapentinGabapentin
    68001-007GabapentinGabapentin
    68071-1212GABAPENTINGABAPENTIN
    68071-1292GabapentinGabapentin
    68071-1808GABAPENTINGABAPENTIN
    68071-1907GABAPENTINGABAPENTIN
    68071-1995GabapentinGabapentin
    68071-3230GABAPENTINGABAPENTIN
    68071-3046GabapentinGabapentin
    68071-3244GabapentinGabapentin
    68071-4087GabapentinGabapentin
    68071-3086GABAPENTINGABAPENTIN
    68071-3383GABAPENTINGABAPENTIN
    68071-3314GABAPENTINGABAPENTIN
    68071-4049GABAPENTINGABAPENTIN
    68071-4241GABAPENTINGABAPENTIN
    68071-4099GabapentinGabapentin
    68071-4113GabapentinGabapentin
    68071-4292GabapentinGabapentin
    68071-4180GabapentinGabapentin
    68071-4090GabapentinGabapentin
    68071-4329GabapentinGabapentin
    68071-4603GabapentinGabapentin
    68071-4169GabapentinGabapentin
    68071-4346GabapentinGabapentin
    68071-4366GabapentinGabapentin
    68071-4729GabapentinGabapentin
    68071-4402GABAPENTINGABAPENTIN
    68071-4784GABAPENTINGABAPENTIN
    68084-774GabapentinGabapentin
    68084-783GabapentinGabapentin
    68084-797GabapentinGabapentin
    68084-762GabapentinGabapentin
    0440-5562GABAPENTINGABAPENTIN
    0440-5563GABAPENTINGABAPENTIN
    68084-802GabapentinGabapentin
    68151-1028GabapentinGabapentin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.